What Science Does The Obesity Code Cite About Insulin Resistance?

Reading 'The Obesity Code' fired up my curiosity about what kind of science Jason Fung actually leans on when he argues that insulin resistance and hyperinsulinemia are central to weight gain. He builds his case from several strands: basic physiology, animal experiments, human observational studies, clinical interventions, and drug-effect observations. On the physiology side he emphasizes insulin’s classic actions—stimulating lipogenesis (fat creation), inhibiting lipolysis (fat breakdown), promoting glucose uptake via AKT/GLUT4 signaling in muscle and fat—and argues that chronically elevated insulin favors net fat storage. That mechanistic background is solid textbook physiology and is one reason the idea feels intuitively plausible to me.

He also leans on specific experimental lines. One famous animal model often mentioned is the fat-specific insulin receptor knockout mouse (FIRKO), which is leaner and protected from diet-induced obesity; Fung uses that to suggest that reducing insulin signaling in fat can limit fat accumulation. There are also rodent infusion studies where raising insulin levels promotes weight gain, and conversely, interventions that lower insulin can reduce fat. In humans he cites observational correlations where elevated fasting insulin or measures like HOMA-IR sometimes precede weight gain, and clinical patterns such as weight gain associated with insulin therapy or insulin-secretagogues (like sulfonylureas) in diabetics.

Then there are intervention studies: short-term trials of low-carbohydrate diets, time-restricted feeding, and intermittent fasting that show big drops in insulin and often big early weight losses. Fung points to bariatric surgery as another interesting example—rapid improvements in insulin levels and insulin sensitivity often precede major weight loss, which he interprets as supporting a causal role for insulin. He also highlights metabolic clamp studies to distinguish peripheral insulin resistance from hepatic insulin resistance and uses that to argue that insulin dynamics are central.

That said, the scientific picture isn’t unanimous. Critics point out that many human trials show long-term weight depends a lot on calories and adherence, that correlation isn’t causation in many observational studies, and that some of the animal work doesn’t translate directly to people. Insulin resistance can be both a cause and an adaptive consequence of overnutrition; hormones like leptin, neural regulation of appetite, gut signals, and behavior also matter. Still, reading the book pushed me to reexamine the insulin literature and try time-restricted eating myself—I've noticed clearer mornings with fewer cravings, which, for me, feels like a tiny victory in understanding how my hormones behave.

I get a little nerdy about this book because 'The Obesity Code' really leans hard into a hormonal model where insulin is the central villain. Fung collects a mix of human and animal physiology papers to argue that chronic hyperinsulinemia — often from frequent eating and high refined-carb diets — drives fat storage and eventually causes cells to downregulate insulin signaling. He points to classic insulin-infusion experiments showing that persistently elevated insulin favors lipogenesis and suppresses lipolysis, and to cohort studies where higher fasting insulin predicts future weight gain and type 2 diabetes more reliably than body mass index alone.

He also brings up mechanistic work: how ectopic lipid accumulation in liver and muscle interferes with insulin signaling pathways, how diacylglycerol-activated PKC isoforms can blunt insulin receptor substrate activity, and how hepatic de novo lipogenesis — stimulated by sugars like fructose — raises intrahepatic fat and worsens systemic insulin responsiveness. Importantly, Fung uses measures like HOMA-IR and references hyperinsulinemic-euglycemic clamp data to explain what clinicians and researchers mean by 'insulin resistance.'

My takeaway is that 'The Obesity Code' stitches together physiology, epidemiology, and interventional studies (like low-carb and fasting trials) to push a cause-first view: hyperinsulinemia causes obesity rather than just being a consequence. It's persuasive in parts, controversial in others, but it definitely changed how I think about meal timing and carbs — feels like a practical nudge to try longer fasting windows.

Reading 'The Obesity Code' made me rethink patient-level evidence and physiological markers. Clinically minded studies he cites include hyperinsulinemic clamp work to quantify peripheral insulin sensitivity, and trials where altering macronutrients or meal timing changed fasting insulin and fat distribution. Fung emphasizes that standard metrics like caloric balance miss hormonal drivers: high circulating insulin favors nutrient partitioning into adipose tissue while preventing fat mobilization. He brings up rodent models showing that constant insulin exposure increases fat mass, and human infusion experiments where raising insulin (with constant glucose) reduces lipolysis.

But I also appreciate that the book acknowledges measurement nuances — HOMA-IR gives a rough estimate while clamps are gold standard but resource-heavy — and that epidemiological links can't prove causation on their own. The mainstream counterpoint is that adipose tissue dysfunction, immune cell infiltration, and lipid spillover contribute to insulin resistance; Fung responds by suggesting hyperinsulinemia sets off many of those downstream processes. Taken together, the cited science supports using approaches that lower insulin exposure as a plausible strategy, and I found that insight useful when coaching lifestyle changes — it felt evidence-informed and actionable in everyday care.

I talk about this with friends who just want clear rules: Fung's core claim in 'The Obesity Code' is that insulin is the fat-storage hormone and that chronically high insulin levels — from lots of carbs, sugary drinks, and constant grazing — promote fat gain and eventually cause tissues to become less responsive to insulin. He points to studies where insulin clamps and infusion experiments directly show that insulin blocks fat breakdown and encourages fat uptake. There are also epidemiological papers he cites that show people with higher fasting insulin are more likely to gain weight and later develop diabetes.

It's not airtight though; many scientists argue insulin resistance also comes from inflammation and adipocyte stress. Still, the practical science he uses (mechanisms, cohort data, and intervention trials) convinced me to try longer fasts and cut back on snacking — it's helped my focus and waistline a bit, which I like.

what I like about the science cited in 'The Obesity Code' is the emphasis on temporal and mechanistic evidence. Fung highlights longitudinal studies where high insulin predicts metabolic decline, acute insulin infusion and clamp studies that show insulin's direct effects on fat metabolism, and interventional trials where reducing insulin through intermittent fasting or low-carb diets tends to lower weight and visceral fat faster than some standard low-fat approaches. He also references biochemical pathways: insulin inhibits hormone-sensitive lipase, promotes lipoprotein lipase in adipose tissue, and drives hepatic DNL (de novo lipogenesis), especially with excess fructose.

That said, the book leans into the idea that hyperinsulinemia is primarily causative, which remains debated. Many researchers argue inflammation, adipocyte dysfunction, and genetic predispositions also play huge roles, and that insulin resistance can be both a cause and consequence in a vicious cycle. Still, if you like a model where lowering insulin exposure (through fewer carbs or time-restricted eating) is a lever you can pull, the science Fung cites gives a coherent rationale. Personally, it pushed me to cut snacking — I felt less bloated and my energy patterns evened out.

I prefer short, practical takes: Fung's narrative is built on a mix of mechanistic biology, animal models, epidemiology, and clinical observations. Mechanistically, insulin drives fat storage by promoting lipogenesis and shutting down lipolysis; that’s straightforward and well-supported. He supplements that with compelling animal data like the FIRKO mice (fat-specific insulin receptor knockouts that resist obesity) and rodent infusion studies where chronic insulin exposure increases fat mass.

On the human side he points to higher fasting insulin or hyperinsulinemia correlating with later weight gain in some cohorts, weight gain seen with insulin or insulin-stimulating diabetes drugs, and trials where lowering insulin through low-carb diets, time-restricted eating, or fasting often produces rapid weight loss and appetite changes. Critics push back that many human RCTs show mixed long-term superiority for any one diet, that insulin resistance may be a marker rather than the root cause, and that behavior and calorie balance still matter for sustained results. Personally, I found the book a useful nudge to experiment with meal timing—my energy and cravings changed when I tightened my eating window, which tells me there's more to explore in how insulin shapes daily habits.